Lansoprazole precipitated QT prolongation and torsade de pointes associated with disopyramide

European Journal of Clinical Pharmacology

Volumn 68, Issue 3, 2012, Pages 331-333

  Asajima, Hiroshi ^a   Saito, Naotaka ^a   Ohmura, Yoshinori ^a   Ohmura, Kazue ^a  

^a HAKODATE CENTRAL GENERAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DISOPYRAMIDE; LANSOPRAZOLE; THIAMAZOLE;

AGED; CASE REPORT; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; FEMALE; GASTROESOPHAGEAL REFLUX; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HUMAN; HYPERTHYROIDISM; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SINUS BRADYCARDIA; SYNCOPE; TORSADE DES POINTES;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; AGED; ANTI-ARRHYTHMIA AGENTS; ANTI-ULCER AGENTS; DISOPYRAMIDE; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; LONG QT SYNDROME; TORSADES DE POINTES;

EID: 84857047797     PISSN: 00316970     EISSN: 14321041     Source Type: Journal    
DOI: 10.1007/s00228-011-1119-z     Document Type: Letter

References (16)

1. DM Roden 2004 Drug-induced prolongation of the QT interval N Engl J Med 350 1013 1022 14999113 10.1056/NEJMra032426 1:CAS:528:DC%2BD2cXhvFGjs7Y%3D (Pubitemid 38269278)
2. DA Gremse 2001 Lansoprazole: pharmacokinetics, pharmacodynamics and clinical uses Expert Opin Pharmacother 2 10 1663 1670 11825309 10.1517/14656566.2.10.1663 1:CAS:528:DC%2BD3MXotlGru7o%3D (Pubitemid 33019734)
3. H Blume F Donath A Warnke BS Schug 2006 Pharmacokinetic drug interaction profiles of proton pump inhibitors Drug Saf 29 769 784 16944963 10.2165/00002018-200629090-00002 1:CAS:528:DC%2BD28XhtV2rtr%2FF (Pubitemid 44352242)
4. S Shi U Klotz 2008 Proton pump inhibitors: an update of their clinical use and pharmacokinetics Eur J Clin Pharmacol 64 935 951 18679668 10.1007/s00228-008-0538-y 1:CAS:528:DC%2BD1cXht1Sqs7jN
5. KP Letsas M Efremidis SP Kounas LK Pappas G Gavrielatos IP Alexanian NP Dimopoulos GS Filippatos A Sideris F Kaedaras 2009 Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors Clin Res Cardiol 98 208 212 19031039 10.1007/s00392-008-0741-y
6. A Gupta AT Lawrence K Krishnan CJ Kavinsky RG Trohman 2007 Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes Am Heart J 153 891 899 17540188 10.1016/j.ahj.2007.01.040 (Pubitemid 46809861)
7. PJ Kannankeril DM Roden 2007 Drug-induced long QT and torsade de pointes: recent advances Curr Opin Cardiol 22 39 43 17143043 10.1097/HCO. 0b013e32801129eb (Pubitemid 44901054)
8. JN Johnson C Grifoni JM Bos M Saber-Ayad SR Ommen S Nistri F Cecchi I Olivotto MJ Ackerrman 2011 Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy Eur Heart J 32 1114 1121 21345853 10.1093/eurheartj/ehr021
9. A Dritsas E Sbarouni D Gilligan P Nihoyannopoulos CM Oakley 1992 QT-interval abnormalities in hypertrophic cardiomyopathy Clin Cardiol 15 739 742 1395184 10.1002/clc.4960151010 1:STN:280:DyaK3s%2FgvFaisQ%3D%3D
10. MV Sherrid I Barac WJ McKenna PM Elliott S Dickie L Chojnowska S Casey BJ Maron 2005 Multicenter study of the efficacy and safety of disopytamide in obstructive hypertrophic cardiomyopathy J Am Coll Cardiol 45 1251 1258 15837258 10.1016/j.jacc.2005.01.012 1:CAS:528:DC%2BD2MXjtlagt7g%3D (Pubitemid 40523146)
11. TC Trujillo PE Nolan 2000 Antiarrhythmic agents: drug interactions of clinical significance Drug Saf 23 509 532 11144659 10.2165/00002018-200023060- 00003 1:CAS:528:DC%2BD3MXhtlektA%3D%3D (Pubitemid 32001513)
12. Z Guo S Raeissi RB White JC Stevens 1997 Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes Drug Metab Dispos 25 390 393 9172960 (Pubitemid 27120588)
13. T Cundy A Dissanayake 2008 Severe hypomagnesaemia in long-term users of proton-pump inhibitors Clin Endoclinol 69 338 341 10.1111/j.1365-2265.2008. 03194.x 1:CAS:528:DC%2BD1cXhtVarsLzM (Pubitemid 352009025)
14. JD Mackay PT Bladon 2010 Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series QJM 103 387 395 20378675 10.1093/qjmed/hcq021 1:CAS:528:DC%2BC3cXmsVOjtbc%3D
15. MA Broeren EA Geerdink HL Vader AW van den Wall Bake 2009 Hypomagnesemia induced by several proton-pump inhibitors Ann Intern Med 151 755 756 19920278
16. LA Siddoway RL Woosley 1986 Clinical pharmacokinetics of disopyramide Clin Pharmacokinet 11 214 222 3524956 10.2165/00003088-198611030-00003 1:STN:280:DyaL283nt12qsA%3D%3D (Pubitemid 16079740)